Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Toxicol Pathol ; 49(7): 1269-1287, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-34555946

RESUMEN

Islet-like clusters derived from human embryonic stem cells (hESC) hold the potential to cure type 1 diabetes mellitus. Differentiation protocols of islet-like clusters lead to the generation of minor fractions of nonendocrine cells, which are mainly from endodermal and mesodermal lineages, and the risk of implanting these is unclear. In the present study, the histogenesis and the tumorigenicity of nonendocrine cells were investigated in vivo. Immunodeficient mice were implanted under the kidney capsule with islet-like clusters which were derived from differentiation of cells batches with either an intermediate or poor cell purity and followed for 8 or 26 weeks. Using immunohistochemistry and other techniques, it was found that the intermediate differentiated cell implants had limited numbers of small duct-like cysts and nonpancreatic tissue resembling gastrointestinal and retinal pigmented epithelium. In contrast, highly proliferative cystic teratomas were found at a high incidence at the implant site after 8 weeks, only in the animals implanted with the poorly differentiated cells. These findings indicate that the risk for teratoma formation and the amount of nonpancreatic tissue can be minimized by careful in-process characterization of the cells and thus highlights the importance of high purity at transplantation and a thorough ex-vivo characterization during cell product development.


Asunto(s)
Diabetes Mellitus Tipo 1 , Células Madre Embrionarias Humanas , Animales , Diferenciación Celular , Humanos , Mesodermo , Ratones
2.
Toxicol Pathol ; 46(7): 777-798, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-30343647

RESUMEN

The obese rodent serves as an indispensable tool for proof-of-concept efficacy and mode-of-action pharmacology studies. Yet the utility of this disease model as an adjunct to the conventional healthy animal in the nonclinical safety evaluation of anti-obesity pharmacotherapies has not been elucidated. Regulatory authorities have recommended employing disease models in toxicology studies when necessary. Our study investigated standard and exploratory toxicology parameters in the high-fat diet (HFD)-induced obese, polygenic Sprague-Dawley rat model in comparison to chow diet (CD)-fed controls. We sought to establish feasibility of the model for safety testing and relevance to human obesity pathophysiology. We report that both sexes fed a 45% kcal HFD for 29 weeks developed obesity and metabolic derangements that mimics to a certain extent, common human obesity. Minor clinical pathologies were observed in both sexes and considered related to CD versus HFD differences. Histopathologically, both sexes exhibited mild obesity-associated findings in brown and subcutaneous white fat, bone, kidneys, liver, lung, pancreas, salivary parotid glands, and skeletal muscle. We conclude that chronic HFD feeding in both sexes led to the development of an obese but otherwise healthy rat. Therefore, the diet-induced obese Sprague-Dawley rat may serve as a suitable model for evaluating toxicity findings encountered with anti-obesity compounds.


Asunto(s)
Dieta Alta en Grasa/efectos adversos , Modelos Animales de Enfermedad , Obesidad/etiología , Animales , Fármacos Antiobesidad/toxicidad , Biomarcadores/sangre , Biomarcadores/orina , Peso Corporal/fisiología , Evaluación Preclínica de Medicamentos , Ciclo Estral/fisiología , Femenino , Masculino , Obesidad/sangre , Obesidad/fisiopatología , Obesidad/orina , Tamaño de los Órganos/fisiología , Especificidad de Órganos/fisiología , Prueba de Estudio Conceptual , Ratas Sprague-Dawley
4.
Toxicol Pathol ; 49(1): 4, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-33393873
5.
Toxicol Pathol ; 43(8): 1047-63, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25948506

RESUMEN

The U.S. Environmental Protection Agency Endocrine Disruptor Screening Program (EDSP) is a multitiered approach to determine the potential for environmental chemicals to alter the endocrine system. The Pubertal Development and Thyroid Function in Intact Juvenile/Peripubertal Female and Male Rats (OPPTS 890.1450, 890.1500) are 2 of the 9 EDSP tier 1 test Guidelines, which assess upstream mechanistic pathways along with downstream morphological end points including histological evaluation of the kidneys, thyroid, and select male/female reproductive tissues (ovaries, uterus, testes, and epididymides). These assays are part of a battery of in vivo and in vitro screens used for initial detection of test article endocrine activity. In this Points to Consider article, we describe tissue processing, evaluation, and nomenclature to aid in standardization of assay results across laboratories. Pubertal assay end points addressed include organ weights, estrous cyclicity, clinical pathology, hormonal assays, and histological evaluation. Potential treatment-related findings that may indicate endocrine disruption are reviewed. Additional tissues that may be useful in assessment of endocrine disruption (vagina, mammary glands, and liver) are discussed. This Points to Consider article is intended to provide information for evaluating peripubertal tissues within the context of individual assay end points, the overall pubertal assay, and tier I assays of the EDSP program.


Asunto(s)
Disruptores Endocrinos/toxicidad , Pubertad/efectos de los fármacos , Pruebas de Función de la Tiroides/métodos , Glándula Tiroides/efectos de los fármacos , Pruebas de Toxicidad/métodos , Animales , Peso Corporal/efectos de los fármacos , Femenino , Masculino , Tamaño de los Órganos/efectos de los fármacos , Ratas
6.
Vet Immunol Immunopathol ; 90(3-4): 179-89, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12459165

RESUMEN

Ovine lentivirus (OvLV) also known as maedi-visna virus, infects and replicates primarily in macrophages. This investigation examined the role of nitric oxide in the replication of OvLV in cultured macrophages. Peripheral blood mononuclear cells were collected from OvLV-free sheep and cultured in Teflon coated flasks at a high concentration of lamb serum. The cells were subsequently infected with OvLV strain 85/34. OvLV replication was assessed under different experimental treatments by comparison of reverse transcriptase (RT) activity in culture supernatant. Cultures that were treated with exogenous nitric oxide via S-nitroso-acetylpenicillamine did not have altered levels of RT activity compared to cultures treated with the inactive control compound, acetylpenicillamine. However, blockage of nitric oxide production by treatment with aminoguanidine, a competitive inhibitor of inducible nitric oxide synthase (iNOS), led to a significant rise in RT activity. This rise in RT activity was partially reversed in aminoguanidine treated cultures by L-arginine, the normal substrate for iNOS. Finally, the number of viral antigen producing cells was also quantified after aminoguanidine treatment and found to be significantly higher than untreated cultures. Collectively, these results indicate that nitric oxide is a negative regulator of OvLV replication in macrophages.


Asunto(s)
Inhibidores Enzimáticos/farmacología , Macrófagos/efectos de los fármacos , Macrófagos/virología , Óxido Nítrico/antagonistas & inhibidores , Oveja Doméstica/virología , Replicación Viral/efectos de los fármacos , Virus Visna-Maedi/efectos de los fármacos , Animales , Antígenos Virales/análisis , Células Cultivadas , Guanidinas/farmacología , Macrófagos/citología , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa/antagonistas & inhibidores , ADN Polimerasa Dirigida por ARN/metabolismo , Virus Visna-Maedi/química , Virus Visna-Maedi/enzimología , Virus Visna-Maedi/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA